A Gene Transfer Therapy Study to Evaluate the Safety of SRP-9004 (Patidistrogene Bexoparvovec) in Participants With Limb-Girdle Muscular Dystrophy, Type 2D (LGMD2D)
Clinical trial NCT01976091 · COMPLETED
Trial details
- NCT number
- NCT01976091
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2019-03-14
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.